It is projected that the counterfeit medication detection devices market sales would expand at a compound annual growth rate (CAGR) of 4.0% between 2022 and 2029, with a valuation of around US$ 1.14 billion in 2022. Forecasts from Future Market Insights indicate that in 2021, counterfeit chemical composition detection devices will account for an estimated 60.6% of the market.
Counterfeit drugs are substandard and falsified drugs and it is a global problem. Counterfeit Drug Detection Devices are the medical devices that are used to detect the counterfeit chemical composition of the drugs and counterfeit packaging and labeling of the drug. The WHO defines a counterfeit drug as any pharmaceutical product that is deliberately mislabeled with respect to identity and/or source.
Counterfeit drugs may include branded and generic products, drugs with the correct ingredients or with the wrong ingredients; without active pharmaceutical ingredient (API), with insufficient active pharmaceutical ingredients (API) or with fake packaging (WHO 2012).
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7838
According to World Health Organization (WHO), counterfeit drugs are estimated around 10% of all pharmaceuticals. North America is the largest economy and largest pharmaceutical market in the world and in spite of strict regulatory policies; maximum drugs that market online are counterfeit. As per estimation from WHO in 2012, the loss suffered by pharmaceutical industry for counterfeit drugs were over US$ 75 Billion.
Counterfeit Drug Detection Market: Drivers and Restraints
With increasing incidence of counterfeit drugs in the world the demand for counterfeit drug detection devices are also increasing. According to Pharmaceutical Security Institute, the number of counterfeit drugs incident has increased from 2,193 in 2013 to 3,509 in 2017. Out of these 3,509 incidents, 1,677 are reported in North America. Medications in the anti-infectives, genito-urinary, and central nervous system (CNS) therapeutic categories were mostly counterfeit.
Counterfeit drug detection devices have advanced enormously from large laboratory set-up to battery operated handheld gadgets. The ease of use, increased efficiency, on-field result and rapid test result are the major factors fuelling the growth of the concerned market. Several government initiatives to combat the counterfeit drug can also a major reason behind the growth of Counterfeit drug detection devices. For example, U.S. FDA has introduced a counterfeit drug detection device for the identification of counterfeit drug and package, the latest version of this counterfeit drug detection device CD-3 is costs around US$ 1,000.
Policy implementation for unit level track-and-trace is another factor fueling the growth of the market. Increased efforts to combat counterfeit drugs by governments and private companies. German customs have started a project called “Blue Project” which enables government to identify illegal online drug-trading sites and the tracing of financial transactions.
Although lack of awareness about the counterfeit drugs can hamper the growth of counterfeit drug detection device market. People are not aware about the technological advancements in counterfeit drug detection device which impending the adoption of new technology handheld devices of counterfeit drug detection devices and can restrain the growth of counterfeit drug detection device market.
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-7838
The devices are costly. High cost of counterfeit drug detection device set-up can restrict the growth of counterfeit drug detection device market.
Counterfeit Drug Detection Device Market: Segmentation
To gain a comprehensive and a better understanding of the future market equity, the Counterfeit Drug Detection Device market report is segmented based on technology, application, end user and region.
Based on the technology type Counterfeit Drug Detection Device is segmented into:
- Infrared and Near Infrared Spectroscopy
- Ultraviolet/Vis
- Microfluidic
- Raman Spectroscopy
- Rapid Chemical Testing
- X-ray diffraction (XRD) and X-ray fluorescence (XRF) Spectroscopy
- RFID Technology
- Scanning and Imaging Systems
- Other Packaging and Labelling Counterfeit Drug Detection Device
Based on application Counterfeit Drug Detection Device Market can be segmented into:
- Counterfeit Drug Detection Device for Chemical Composition
- Counterfeit Drug Detection Device for Packaging & Labelling Detection
Based on end user, Counterfeit Drug Detection Device Market can be segmented into:
- Pharmaceutical companies
- Drug testing laboratories
- Research organizations
On the basis of geography, Counterfeit Drug Detection Device can be segmented as:
- North- America
- Eastern Europe
- Western Europe
- Asia-Pacific excluding China & Japan
- China
- Japan
- Middle East and Africa
- Latin America
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
